mRNA Therapeutics Fast-to-Market Strategies PDF

This book is the most comprehensive and complete treatise on nucleic acid therapeutic

products, including mRNA vaccines, their manufacturing, formulations, and

testing for safety and efficacy. Details include cGMP-compliant manufacturing and

regulatory filing steps. A new concept of “biosimilar” mRNA vaccine is presented

to secure fast approval of copies of mRNA vaccines. Projections of financial plans

to establish RNA manufacturing facilities are provided, along with details of supply

chain management. Finally, the future of nucleic acid products in gene therapy and

other newer applications is presented, along with a perspective that all new vaccines

will be the nucleic acid type that will further provide first-time prevention of autoimmune

disorders. It is projected that both big pharma and start-ups will enter this field,

and we can expect significant additions to our drug armamentarium soon.

Author: Sarfaraz K. Niazi